S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Highly Profitable Restaurant Brand Expands to Canada (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Highly Profitable Restaurant Brand Expands to Canada (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Highly Profitable Restaurant Brand Expands to Canada (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Highly Profitable Restaurant Brand Expands to Canada (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Highly Profitable Restaurant Brand Expands to Canada (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
NYSE:NBY

NovaBay Pharmaceuticals (NBY) Stock Forecast, Price & News

$0.65
0.00 (0.00%)
(As of 05/31/2023 ET)
Compare
Today's Range
$0.61
$0.65
50-Day Range
N/A
52-Week Range
$0.61
$12.64
Volume
145,257 shs
Average Volume
291,488 shs
Market Capitalization
$1.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Receive NBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NBY Stock News Headlines

See More Headlines
Receive NBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NBY Company Calendar

Today
6/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-10,610,000.00
Pretax Margin
-89.72%

Debt

Sales & Book Value

Annual Sales
$14.40 million
Book Value
$2.17 per share

Miscellaneous

Free Float
2,694,000
Market Cap
$1.77 million
Optionable
Not Optionable
Beta
2.72

Key Executives

  • Justin M. Hall
    President, CEO, Director & General Counsel
  • Tommy Law
    Chief Financial Officer, Treasurer & Controller
  • Audrey G. Kunin
    Director & Chief Product Officer













NBY Stock - Frequently Asked Questions

How have NBY shares performed in 2023?

NovaBay Pharmaceuticals' stock was trading at $0.6796 at the beginning of the year. Since then, NBY stock has decreased by 4.4% and is now trading at $0.6499.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of NovaBay Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NovaBay Pharmaceuticals investors own include OpGen (OPGN) and Abbott Laboratories (ABT).

What is NovaBay Pharmaceuticals' stock symbol?

NovaBay Pharmaceuticals trades on the New York Stock Exchange (NYSE) under the ticker symbol "NBY."

How do I buy shares of NovaBay Pharmaceuticals?

Shares of NBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NovaBay Pharmaceuticals' stock price today?

One share of NBY stock can currently be purchased for approximately $0.65.

How much money does NovaBay Pharmaceuticals make?

NovaBay Pharmaceuticals (NYSE:NBY) has a market capitalization of $1.77 million and generates $14.40 million in revenue each year. The company earns $-10,610,000.00 in net income (profit) each year or ($10.0751) on an earnings per share basis.

How can I contact NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals' mailing address is 2000 POWELL STREET SUITE 1150, EMERYVILLE CA, 94608. The official website for the company is novabay.com. The company can be reached via phone at (510) 899-8800, via email at jcain@lhai.com, or via fax at 510-474-1577.

This page (NYSE:NBY) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -